Is My IUD Making Me Crazy? Mood Changes Explained

Hormonal IUDs can affect mood in some users, and the evidence behind that claim has grown substantially in recent years. Large national studies following hundreds of thousands of women have found a statistically meaningful link between levonorgestrel-releasing IUDs and new diagnoses of depression, with the risk appearing to scale with the hormone dose. But “can affect mood” is not “will make you feel crazy,” and the research paints a picture that is more specific and more useful than a simple yes or no.

What the Largest Studies Actually Found

The strongest evidence comes from Scandinavian countries, where national health registries track virtually every prescription, diagnosis, and medical device. A Swedish register-based study covering more than 700,000 women found that those who used a levonorgestrel IUD had a 57% higher rate of being diagnosed with depression compared to women who did not use one.¹ A separate Danish cohort study of about 149,000 first-time users compared different IUD doses and found that the one-year risk of a new depression diagnosis ranged from roughly 1.2% with a low-dose device to roughly 1.8% with a high-dose one.² Those are small percentages in absolute terms, but the pattern held even after the researchers adjusted for age, education, family psychiatric history, and gynecological conditions like endometriosis.

These numbers do not mean the IUD “causes” depression in a strict scientific sense. The studies are observational, so they can identify associations but cannot rule out every confounding factor. Women who choose an IUD may differ from women who choose other contraception in ways the data cannot fully capture. Still, the dose-response pattern across both studies is difficult to dismiss. When the risk rises in proportion to how much levonorgestrel the device releases, it points away from coincidence.

Why a “Local” Device Affects Your Whole Body

One reason mood effects from a hormonal IUD surprise people is that the device is marketed as working locally, inside the uterus. That framing is not wrong, but it is incomplete. The levonorgestrel released by the IUD does reach your bloodstream. A study measuring plasma levels in IUD users found average concentrations of about 191 pg/mL during the first year, declining to around 134 pg/mL by the third year, and still measurable even beyond the device’s approved lifespan.³ Those concentrations are lower than what you would get from a daily birth control pill, but they are not zero, and they are continuous. Your body is exposed to a low but steady stream of synthetic progestin for years.

Body weight also plays a role in how much circulating hormone you end up with. The same study found that higher BMI was associated with lower plasma levels, which makes pharmacological sense: the same amount of drug is distributed across more tissue. Whether that translates into fewer mood effects in larger-bodied users has not been directly tested, but it is a plausible piece of the puzzle.

One important detail often missing from discussions about IUDs and mood: most women using a levonorgestrel IUD continue to ovulate. Fewer than 15% become consistently anovulatory by the end of the first year.⁴ That means your ovaries are still cycling through their natural hormonal fluctuations on top of the steady background levonorgestrel exposure. For people with conditions like PMDD, where mood is tightly linked to ovarian hormone shifts, an IUD that preserves ovulation while adding a synthetic progestin may not solve and could potentially complicate the picture.

What Levonorgestrel Does Inside the Brain

Animal research has identified at least one plausible mechanism linking levonorgestrel to mood changes. In a study on rats, long-term levonorgestrel administration reduced brain levels of allopregnanolone, a naturally occurring neurosteroid that calms the nervous system by enhancing the activity of GABA receptors (the same receptors targeted by anti-anxiety medications like benzodiazepines). Cortical levels dropped by about 75%, and the treated animals showed measurably more anxiety-like behavior.⁵ The researchers noted that the anxiety effects were driven specifically by levonorgestrel, not by the estrogen component also used in combined oral contraceptives.

Translating animal neuroscience directly to human experience is always a leap. Rats cannot report feeling “off” or irritable or unlike themselves. But the finding matters because it identifies a concrete pathway: synthetic progestin displaces a calming neurosteroid, the brain’s inhibitory signaling changes, and behavior shifts toward anxiety. That is the kind of mechanism that makes the epidemiological associations more biologically credible.

The Stress Response Debate

Whether hormonal IUDs change how your body responds to stress has been directly tested, and the results are conflicting enough to be worth walking through. One study exposed IUD users, pill users, and non-hormonal-contraception users to a standardized lab stress test and measured their cortisol output. The IUD group had a dramatically exaggerated cortisol spike compared to both other groups, and their hair cortisol (a marker of chronic stress exposure over months) was also elevated.⁶ The researchers interpreted this as evidence that the IUD sensitizes the stress-response system at a central level.

But a later prospective study tracked women before and after IUD insertion and found that hair cortisol concentrations were similar whether women got a hormonal or a copper (non-hormonal) IUD. Psychometric questionnaires in that study also did not show worsened mood.⁷ And a 2025 study published in the British Journal of Psychiatry found that IUD users did not differ from non-contraceptive-using women in their cortisol response to stress, though oral contraceptive users showed a blunted response compared to both groups.⁸

So the cortisol picture is genuinely unsettled. One well-designed study says the IUD cranks up stress reactivity; two others say it does not. The differences may come down to study populations, how long participants had been using the device, or unmeasured variables. For you as a reader, the takeaway is that a heightened stress response is a plausible but not established consequence of hormonal IUD use. If you feel like you are overreacting to stressors that used to roll off you, it is worth considering the IUD as a factor, but other explanations (life changes, sleep, workload) deserve equal scrutiny.

It Is Not Just About Depression

The research conversation around IUDs and mood tends to center on depression because that is the easiest outcome to track in large databases. But the symptom profile that users describe is broader. A UK cohort study found that levonorgestrel IUD users who had no prior psychiatric history had a roughly 18% higher rate of new anxiety diagnoses and a roughly 22% higher rate of new sleep problems compared to non-users.⁹ The same study found no significant link with panic attacks or restlessness, so the effects, where they exist, seem to track more along the lines of generalized unease and disrupted sleep rather than acute episodes.

A systematic review that pulled together 22 studies on the topic found a genuinely mixed landscape: ten studies reported increased depressive symptoms, two reported reduced symptoms, four found no association, and the remaining studies were uncertain or flagged other psychiatric effects including anxiety and suicidality.¹⁰ That kind of inconsistency frustrates everyone, clinicians and patients alike, but it is consistent with a picture where the IUD genuinely affects a subset of users while leaving the majority unchanged.

If your experience has been more along the lines of irritability, low-grade anxiety, insomnia, or emotional flatness rather than textbook depression, you are not imagining things. Those symptoms are harder to capture in registries that track formal diagnoses, which means they are probably underrepresented in the research.

Who Is Most Vulnerable

Age is the single biggest risk modifier the research has identified. The Swedish study found that adolescents using a levonorgestrel IUD had more than double the risk of depression compared to teens not using hormonal contraception, a far steeper increase than in older users.¹ The same study found a heightened risk among women using the IUD as their very first hormonal contraceptive, suggesting that an introduction to exogenous hormones, at any age, may be a more vulnerable window than a switch from one method to another.

An updated review of hormonal contraception and mood disorders concluded that the two most reliable predictors of depressive symptoms after starting hormonal contraception are age at onset of use and personal or family history of mental health conditions.¹¹ If you have had depression or anxiety before, starting a hormonal IUD deserves a conversation with your provider about monitoring. That does not mean you cannot use one, but going in aware that you may be more sensitive to mood effects is better than being caught off guard.

What about people in their late thirties and forties who get an IUD partly for heavy bleeding management? The Danish study’s high-dose group had an average age of 30, and IUDs prescribed for menorrhagia or fibroids tend to be the 52 mg (highest-dose) version. That is worth knowing: if you are getting an IUD primarily for period control rather than contraception, you are likely getting the formulation with the highest observed depression signal.

Does the Dose of the IUD Matter

Yes, and this is one of the more actionable findings from recent research. Hormonal IUDs come in different levonorgestrel loads. The highest-dose device contains 52 mg. Lower-dose options contain 19.5 mg or 13.5 mg and release correspondingly less hormone over their lifespan. A large Danish study estimated that for every 1,000 women using the device over its approved duration, switching from the 52 mg to a 19.5 mg device would spare roughly 11 women a depression diagnosis, and switching to the 13.5 mg device would spare about 13.¹² The two lower-dose devices did not differ meaningfully from each other in depression risk.

Those differences persisted even after adjusting for confounders, and the dose-response gradient was consistent with the separate Danish study described earlier.² The reduction in depression risk with lower-dose devices did shrink somewhat over longer durations of use, which makes sense given that all IUDs release less hormone as they age. Still, if you are considering a hormonal IUD and mood is a concern, asking your provider about a lower-dose option is a reasonable conversation to have. The trade-off is that lower-dose devices may be somewhat less effective at managing very heavy bleeding, which is why the 52 mg version is often the default prescription for that indication.

What Happens After Removal

One of the most reassuring details in this area is that mood symptoms linked to the IUD tend to resolve after the device comes out. Published case reports document rapid and sometimes dramatic improvement. In one documented case, a woman who developed severe depression with panic attacks after IUD placement saw her symptoms improve markedly within two weeks of removal, and by four weeks her depression and anxiety had fully resolved. At six- and twelve-month follow-ups, she remained symptom-free.¹³

A case report is the weakest form of clinical evidence, and plenty of people remove their IUD and find their mood does not change. But the speed and completeness of recovery in documented cases is consistent with a pharmacological effect rather than a coincidence. If you suspect your IUD is affecting your mental health, removal is a reversible test. You can always get another one if the symptoms turn out to have nothing to do with the device.

A practical note: some providers are dismissive when patients raise mood concerns about IUDs, partly because until recently the clinical consensus leaned heavily on the “it’s local, not systemic” framing. Research on how patients navigate these conversations has found that women often validate their own experiences through tracking symptoms, self-experimentation (such as noting changes after removal and reinsertion), and sharing information on social media.¹⁴ If your provider is not engaging with your concerns, seeking a second opinion is entirely appropriate. The evidence base has shifted enough that “IUDs don’t affect mood” is no longer a defensible clinical position.

The Copper IUD as a Comparison

The copper IUD (sold in the US as Paragard) releases no hormones at all. It works through a local inflammatory reaction that is toxic to sperm. Because it has no systemic hormonal component, it serves as a useful control in mood research. The prospective cortisol study mentioned earlier found no difference in stress markers between women who got a hormonal IUD and women who got a copper one.⁷ But the large registry studies that show mood effects are comparing hormonal IUD users to the general population, not specifically to copper IUD users, which is a methodological limitation worth noting.

If mood is your primary concern and you still want an IUD, a copper device sidesteps the levonorgestrel question entirely. The trade-off is different side effects: heavier and more painful periods are common, especially in the first few months. For some people that is a dealbreaker. But if you have a history of mood sensitivity to hormones, the copper IUD gives you the same convenience and effectiveness of an IUD without the hormonal variable.

Sexual Function and Quality of Life

Mood is not the only dimension of well-being that users wonder about. A systematic review looking at how IUDs affect sexual function found that levonorgestrel IUDs generally had a positive effect on sexual pain and a neutral to slightly positive effect on desire. Other domains, including arousal, lubrication, orgasm, and overall satisfaction, were largely unaffected.¹⁵ The improvement in sexual pain may relate to reduced menstrual flow and lighter periods rather than a direct hormonal effect on libido.

This matters because mood and sexual satisfaction are tangled together in ways that make it hard to separate causes. If your IUD dramatically reduces painful periods and gives you peace of mind about pregnancy, those quality-of-life gains can outweigh a modest increase in mood symptoms. Conversely, if the mood effects are severe enough to dampen your interest in sex or your relationships, the calculus shifts. There is no universal right answer, only a personal one that weighs the specific benefits and drawbacks you are experiencing.

Why Female Brains May Be More Sensitive to Hormonal Disruption

Research on neuroinflammation and sex differences has found that female brains show greater inflammatory responsiveness during adolescence and adulthood, particularly after stress exposure, compared to male brains.¹⁶ This heightened neuroimmune reactivity may partly explain why women are more susceptible to mood disorders generally and why introducing exogenous hormones during hormonally sensitive windows (adolescence, the postpartum period, perimenopause) can have outsized effects. It also aligns with the observation from the Swedish registry data that adolescents were the most affected age group. Their brains are still undergoing development in regions critical for emotional regulation, and layering a synthetic progestin onto that process appears to carry a higher risk than doing so in a mature adult brain.

None of this means hormonal IUDs are dangerous or that most users will experience psychiatric effects. The absolute risk numbers from the large Danish study, ranging from about 1.2% to 1.8% over one year, mean that the vast majority of users will not develop a clinical mood disorder attributable to the device. But for the minority who do, the experience can be genuinely disabling, and the evidence now supports taking those reports seriously rather than attributing them to coincidence or pre-existing vulnerability alone.